In addition, berberine inhibited prostate cancer cell invasion and migration by downregulating several EMT-related genes, such as platelet-derived growth factor receptor-beta (PDGFRB), collagen, type I, alpha 2 (COL1A2), and bone morphogenetic protein 7 (BMP7) [114]. This evidence concerns the gene COL1A2 and prostate carcinoma.